St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Craniopharyngioma is a brain tumor found in the area of the brain around the nerves to the eyes (optic pathway) and the pituitary gland (produces the body’s hormones). Craniopharyngiomas account for about 6% of childhood brain tumors. There are around 100–120 cases of pediatric craniopharyngioma in the United States each year. Diagnosis most often occurs between ages 5–14.
This is often a solid and cystic tumor. Its growth can result in serious illness, vision problems, and problems with hormone levels. The tumor does not usually spread to other areas of the brain or spinal cord.
The 10-year survival rate for craniopharyngioma is about 80–90%.
Learn more about craniopharyngioma on the Together by St. Jude™ online resource.
Sometimes craniopharyngiomas can be diagnosed by imaging alone based on characteristic features you can see on both CT scans and MRI scans. If surgery is performed, further molecular testing can be done to identify the type of craniopharyngioma.
There are 2 types of craniopharyngiomas:
Treatments for craniopharyngioma include surgery, radiation therapy, or both.
Surgery may:
Radiation therapy can be used alone or with surgery.
St. Jude has developed effective treatments with the least amount of risk based on the tumor’s features. This approach is used to increase survival rates and lower the risk of side effects of treatment. If the patient’s prognosis is good, a less intense therapy can be offered. Patients with high-risk disease may receive more intensive therapy to improve their chances of survival.
St. Jude clinical trials have produced new, groundbreaking treatments for serious childhood diseases. Our doctors and scientists work together to find better ways to treat patients. In many cases, new treatments are being developed on the St. Jude campus.
We also take part in trials developed by the Children’s Oncology Group (COG) and the Pediatric Brain Tumor Consortium (PBTC). Many of our faculty members play key roles in developing these large trials that take place at centers across the United States.
Study goal:
The main goal of this study is to learn if proton therapy will treat patients with craniopharyngioma brain tumors effectively and reduce side effects compared to traditional forms of radiation therapy.
Age:
21 years old or younger
St. Jude provides the highest quality of care for patients with craniopharyngioma:
More reasons to choose St. Jude for care include:
Get more information about the Brain Tumor Treatment program at St. Jude.
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
You can start the referral process by letting your doctor know you would like a second opinion from St. Jude. They can contact our 24-hour beeper service or contact our brain tumor coordinator. You may also contact the brain tumor coordinator directly with questions.
Learn more about the types of brain tumors we treat at St. Jude and our brain tumor eligibility requirements.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Email: referralinfo@stjude.org
Fax: 901-595-4011 | 24-hour pager: 1-800-349-4334
Contact the Brain Tumor Team directly:
Contact the Surgery Team directly: